Hussain Iqbal J

Chief Legal OfficerCentessa Pharmaceuticals plc (CNTA) · full profile →Form 4 · filed Jun 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
2 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Disposed to issuer(D)118K0
Jun 24, 2026Disposed to issuer(D)6K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Disposed to issuer(D)222K0
Jun 24, 2026Disposed to issuer(D)167K0
Jun 24, 2026Disposed to issuer(D)100K0
Jun 24, 2026Disposed to issuer(D)160K0
Jun 24, 2026Disposed to issuer(D)100K0
Jun 24, 2026Disposed to issuer(D)170K0
Jun 24, 2026Disposed to issuer(D)175K0
Jun 24, 2026Disposed to issuer(D)160K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000622) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.